Pituitary apoplexy.


Journal

Neurologia i neurochirurgia polska
ISSN: 0028-3843
Titre abrégé: Neurol Neurochir Pol
Pays: Poland
ID NLM: 0101265

Informations de publication

Date de publication:
2019
Historique:
received: 12 05 2019
accepted: 07 09 2019
revised: 06 09 2019
pubmed: 21 11 2019
medline: 7 1 2020
entrez: 21 11 2019
Statut: ppublish

Résumé

Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage and/or infarction of the pituitary gland, generally within a frequently undiagnosed pituitary adenoma. The sudden increase in pituitary gland volume is responsible for typical symptoms: severe headache, nausea, vomiting, visual impairment, cranial nerve palsies, deteriorating level of consciousness, and hypopituitarism. Radiological evidence, especially magnetic resonance imaging (MRI) which is the most sensitive diagnostic modality, establishes the diagnosis. Multiple risk factors have been reported, although the majority of cases have no identifiable precipitants. The management strategy depends on the clinical manifestation, as well as the presence of co-morbidities, and remains controversial. Post apoplexy, there needs to be careful monitoring for recurrence of tumour growth and endocrinological function of the pituitary. This disease is rare but potentially life-threatening without rapid treatment. Because there are no randomised studies, it is suggested that further trials are needed to optimise proper management.

Identifiants

pubmed: 31745969
pii: VM/OJS/J/64302
doi: 10.5603/PJNNS.a2019.0054
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-420

Auteurs

Małgorzata Wichlińska-Lubińska (M)

Department of Neurology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland. wichlinska@o2.pl.

Grzegorz Kozera (G)

Department of Neurology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH